Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(2 sites)
United States
Massachusetts General Hospital, Boston, Massachusetts Vanderbilt University Medical Center, Nashville, Tennessee Last updated February 2026